Author: healthprofessionalradio

Drs. Silvia Morris, MD, Diane Boykin, MD, and Angela Walker, MD, discuss their new book “The Game Plan: A Woman’s Guide to Becoming a Doctor and Living a Life in Medicine.” They talk about medical career pathways, why more female doctors are needed in the profession, and share about their own careers.

Dr. David Neubauer, MD, Associate Professor of Psychiatry and Behavioral Sciences at Johns Hopkins Medicine discusses the current landscape of insomnia treatments and the petition for the DEA to de-schedule the Dual Orexin Receptor Antagonists (DORAs) class of insomnia medications which offer an entirely different approach to treating insomnia and meets an unmet need for longer-term use with little risk of dependence.

Mei Mei Hu, CEO of Vaxxinity, discusses the company’s approach to targeting a wide variety of chronic diseases such as Alzheimer’s, Parkinson’s, migraine, and hypercholesterolemia, as well as their COVID-19 booster vaccine. Vaxxinity aims to utilize its unique synthetic peptide platform technology to bring the convenience, efficiency, and cost-effectiveness of vaccines to the treatment and prevention of chronic diseases — making critical medicines available to all. For more information on Vaxxinity visit https://vaxxinity.com.

Dr. Emri Seli, March of Dimes Chief Scientific Officer and Professor of Obstetrics, Gynecology, and Reproductive Sciences at Yale School of Medicine discusses the March of Dimes‘ increased focus on recurrent pregnancy loss (RPL) and the work March of Dimes researchers will perform to gather new insights into RPL through the lens of environmental factors.

Dr. Ron Silverman, MD, Senior Vice President, Global Medical and Clinical Affairs and Chief Medical Officer at 3M discusses how the company’s AI and automation technology has helped healthcare providers increase efficiency and focus more on patient care. To reduce physician burnout and streamline processes, 3M has developed software and services to help identify, prioritize, and address documentation gaps in real-time that can impact care, quality, and financial success with AI-powered CDI and integrated CAPD. 3M CDI Engage One uses encounter-based clinical reasoning and automation to analyze EHR notes and narrative documents in real-time to help close gaps in patient care and clinical documentation.

Returning guest, Dr. Michael Irizarry, Senior Vice President and Deputy Chief Clinical Officer, Alzheimer’s Disease and Brain Health, at Eisai Inc. discusses the U.S. Food and Drug Administration’s (FDA) traditional approval of LEQEMBI ® (lecanemab-irmb) 100 mg/mL injection for intravenous use as the first and only disease-modifying treatment for Alzheimer’s disease (AD).

Dr. Laura Korb Ferris, MD, PhD, Professor, University of Pittsburgh Clinical and Translational Science Institute and Director of Clinical Trials, UPMC Department of Dermatology discusses the new phase 2b FRONTIER 1 study data that demonstrates the potential of JNJ-2113, the novel first and only oral IL-23 antagonist peptide to “potentially change the treatment paradigm” for patients with moderate to severe plaque psoriasis. She talks about why this data may be encouraging for patients and prescribers.

Ali Carbone, sister to three brothers with autism, discusses her new memoir called “What Are You Looking At?” Ali shares her firsthand perspective and gives light to the untold stories of siblings with intellectual and developmental disabilities (IDD).

Returning guest, Dr. Roy Herbst, MD, PhD, from the Yale School of Medicine and primary investigatory of the ADAURA Phase III trial discusses the positive results that show TAGRISSO ® (osimertinib) demonstrated a statistically significant and clinically meaningful improvement in overall survival (OS), with 88% of patients alive at five years compared to placebo in the adjuvant treatment of patients with certain types of non-small cell lung cancer (NSCLC). These results were presented during the Plenary Session at the 2023 ASCO Annual Meeting (abstract #LBA3).